At 2:15 p.m. ET, a joint symposium of the ADA and the International Society for Pediatric and Adolescent Diabetes featuring Richard A. Oram, MD, PhD, and R. Brett McQueen, PhD, will consider general population screening versus targeted screening.
Up next: Experts will weigh benefits, challenges of type 1 diabetes screening
